The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the gene therapy used to be the pariah of medical treatments because it was thought to be dangerous risky probably won't work that's gone at 180 and now if you have a gene therapy company they've been a few they're being sold in the billions recently these are extremely hot everything that's new breaking new ground investors are all over it
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
the gene therapy used to be the pariah of medical treatments because it was thought to be dangerous risky probably won't work that's gone at 180 and now if you have a gene therapy company they've been a few they're being sold in the billions recently